Longterm renal outcome after 10 years enzyme replacement therapy with agalsidase A in Fabry male patients

被引：0
|
作者：
Karabul, Nesrin [1 ]
Arash, Laila [1 ]
Waechter, Maike [1 ]
Beck, Michael [1 ]
Kampmann, Christof [1 ]
Mengel, Eugen [1 ]
机构：
[1] Villa Metabol, Mainz, Germany
来源：
MOLECULAR GENETICS AND METABOLISM | 2014年 / 111卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2013.12.130
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
118
引用
收藏
页码：S59 / S60
页数：2
相关论文
共 50 条
  • [11] Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy
    Mignani, Renzo
    Feriozzi, Sandro
    Pisani, Antonio
    Cioni, Antonio
    Comotti, Cristina
    Cossu, Maria
    Foschi, Annalisa
    Giudicissi, Antonio
    Gotti, Eliana
    Lozupone, Vito Antonio
    Marchini, Francesco
    Martinelli, Fabrizio
    Bianco, Francesco
    Panichi, Vincenzo
    Procaccini, Deni Aldo
    Ragazzoni, Elena
    Serra, Andrea
    Soliani, Fausto
    Spinelli, Letizia
    Torti, Giacomo
    Veroux, Massimiliano
    Cianciaruso, Bruno
    Cagnoli, Leonardo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (05) : 1628 - 1635
  • [12] MAJOR STROKE IN FABRY PATIENTS UNDER ENZYME REPLACEMENT THERAPY WITH AGALSIDASE ALFA
    Roland, D.
    Dehout, F.
    Van Maldergem, L.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 167 - 167
  • [13] Agalsidase alfa for enzyme-replacement therapy in Fabry disease
    Mehta, Atul
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (05) : 641 - 652
  • [14] NEUROLOGIC ASSESSMENT IN PATIENTS WITH FABRY DISEASE BEFORE AND AFTER ENZYME REPLACEMENT THERAPY (ERT) WITH AGALSIDASE BETA
    Mendes, C. S. C.
    Rand, M. H.
    Kyosen, S. O.
    Martins, A. M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S157 - S157
  • [15] Enzyme replacement therapy with agalsidase alfa in children with Fabry disease
    Ramaswami, U.
    Wendt, S.
    Pintos-Morell, G.
    Parini, R.
    Whybra, C.
    Leon Leal, J. A.
    Santus, F.
    Beck, M.
    ACTA PAEDIATRICA, 2007, 96 (01) : 122 - 127
  • [16] Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa
    Wendt, S
    Whybra, C
    Kampmann, C
    Teichmann, E
    Beck, M
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (05) : 787 - 788
  • [17] POSITIVE RESULTS FROM 3 YEARS OF ENZYME REPLACEMENT THERAPY WITH AGALSIDASE ALFA IN FABRY DISEASE: DATA FROM FOS - THE FABRY OUTCOME SURVEY
    Beck, M.
    Sunder-Plassmann, G.
    Mehta, A.
    Widmer, U.
    Linhart, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 164 - 164
  • [18] Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfa
    Abcde, Hsiang-Yu Lin
    Huang, Yu-Hsiu
    Liao, Hsuan-Chieh
    Liu, Hao-Chuan
    Hsu, Ting-Rong
    Shen, Chia-I
    Li, Shao-Tzu
    Li, Cheng-Fang
    Lee, Li-Hong
    Lee, Pi-Chang
    Huang, Chun-Kai
    Chiang, Chuan-Chi
    Lin, Shuan-Pei
    Niu, Dau-Ming
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2014, 77 (04) : 190 - 197
  • [19] Uneventful pregnancy outcome after enzyme replacement therapy with agalsidase beta in a heterozygous female with Fabry disease: A case report
    Germain, Dominique P.
    Bruneval, Patrick
    Tran, Thi-Chien
    Balouet, Pierre
    Richalet, Bernard
    Benistan, Karelle
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2010, 53 (02) : 111 - 112
  • [20] Cardio-renal outcomes with long-term agalsidase alfa enzyme replacement therapy: A 10-year Fabry Outcome Survey analysis
    Ramaswami, Uma
    Beck, Michael
    Hughes, Derralynn
    Kampmann, Christoph
    Bizjajeva, Svetlana
    Pintos-Morell, Guillem
    West, Michael
    Niu, Dau-Ming
    Nicholls, Kathy
    Giugliani, Roberto
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S98 - S98
12345